Related Experiment Video
Updated: Aug 14, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Molecular basis of Japanese variants of pyrimidine 5'-nucleotidase deficiency
Hitoshi Kanno1, Takenori Takizawa, Shiro Miwa
1Department of Transfusion Medicine and Cell Processing, Tokyo Women's Medical University, Tokyo, Japan. hikanno@clabo.twmu.ac.jp
Abstract:
The type-I isoform of pyrimidine 5'-nucleotidase (P5N-I) has an important role in the catabolism of pyrimidine mononucleotides during erythroid maturation. Two alternatively spliced forms of P5N-I mRNA have been identified, and we found another alternatively spliced form in reticulocytes, which included an additional 87-bp sequence. The sequence is located 6.2-kb downstream of the exon 2 and 2.7-kb upstream of the exon 3 sequence; consequently, the P5N-I gene encodes 11 exons, which span approximately 48 kb. We identified five novel mutations in nine families with P5N-I deficiency: two missense mutations (425C, 721C), one splice mutation (339C), one 1-bp insertion (251-insA-252) and one 9-bp deletion (del 192-200). All patients were homozygous for each mutation. The mutant P5N-I with 721C (G241R) had lower affinity for cytidine monophosphate, suggesting that Gly241 is important for substrate binding. Haplotype analysis showed that 721C, which had been identified in five unrelated families, was a founder mutation. The mutant P5N was then expressed in Cos-7. The degradation of P5N with 425C (L142P) was significantly faster than a wild-type control, and proteasome inhibitors restored the stability of L142P. These data suggest that L142P increases susceptibility to the degradation by the ubiquitin-proteasome pathway.
Insights
Pyrimidine 5'-nucleotidase (P5N-I) deficiency is caused by novel mutations affecting erythroid maturation. These mutations impact substrate binding and protein stability, with one identified as a founder mutation.
Area of Science:
- Biochemistry
- Genetics
- Hematology
Background:
- Pyrimidine 5'-nucleotidase (P5N-I) is crucial for pyrimidine mononucleotide catabolism during red blood cell development.
- Alternative splicing of P5N-I mRNA contributes to its functional diversity.
- P5N-I deficiency leads to impaired erythroid maturation.
Purpose of the Study:
- To identify genetic mutations responsible for P5N-I deficiency.
- To investigate the functional consequences of identified P5N-I mutations on enzyme activity and stability.
- To analyze the inheritance patterns and origins of specific mutations.
Main Methods:
- Genetic analysis of nine families with P5N-I deficiency.
- Identification and characterization of novel mutations (missense, splice, insertion, deletion).
- In vitro expression studies in Cos-7 cells to assess mutant protein function and degradation pathways.
Main Results:
- Five novel mutations in the P5N-I gene were identified in patients with P5N-I deficiency.
- The G241R mutation (721C) demonstrated reduced affinity for cytidine monophosphate, indicating impaired substrate binding.
- The L142P mutation (425C) resulted in accelerated protein degradation via the ubiquitin-proteasome pathway.
- Haplotype analysis revealed the 721C mutation as a founder mutation in five unrelated families.
Conclusions:
- Novel mutations in the P5N-I gene cause P5N-I deficiency, affecting erythroid maturation.
- Specific mutations impact enzyme substrate binding and protein stability.
- Understanding these mutations provides insights into the molecular basis of P5N-I deficiency and its inheritance.
More Related Videos
05:58Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
Published on: August 20, 2018
06:21Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
Related Concept Videos
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Transfer RNA Synthesis
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Biosynthesis of Nucleic Acids